Trial Code
Ages
Location
Gender
Ethnicity
Payment
Nicotine Restrictions
Duration of stay
Clinical trial summary
We are conducting a clinical trial for a new investigational drug that could be used to help patients who will undergo stem cell transplant. The drug is considered ‘investigational’ as it is not yet approved by any public health agency for any kind of treatment.
In this clinical trial we are recruiting healthy male and female participants aged 18 to 55 years. We will observe how safe and tolerable the investigational drug is, how your body processes the new investigational drug and how long it stays in your body. You will be paid for your time if you take part in this clinical trial.
If you are interested in participating in the trial:
You will need to attend a screening appointment so we can check if you are suitable to take part in the trial. At this appointment we will take blood, check your heart and carry out a physical examination.
- If results from your screening appointment show you are suitable for the trial, you will be invited to take part.
- This will involve a stay of 4 days /3 nights in our clinical research unit.
- After your stay with us you will be required to return for further appointments on Day 8, Day 11, Day 15, Day 22, Day 29, Day 36, Day 43, Day 50, Day 57, Day 91 and Day 121. This means the whole process takes approximately up to 5 months from your screening visit through to your final visit.
- In total, if you are included in the clinical trial you will come to the research unit 13 times.
- During your stay with us you will receive a single dose of investigational drug into your vein, and we will conduct a number of assessments (like those we did at screening) to check how well you tolerate the new investigational drug, and to help us understand how long it takes for your body to process the new investigational drug.
Who can take part?
We will check your suitability for the clinical trial using the following criteria:
- Aged between 18 to 55 years.
- Are generally in good health based on screening assessments and medical history.
- Have a body mass index (BMI) of 18.5 to 25 kg/m2.
- Willing to comply with the contraceptive requirements of the study.
- You do not have any allergy to aspirin or non-steroidal anti-inflammatory drugs (NSAIDs).
- You must be able and willing to provide informed consent.
- You must be willing and able to comply with study requirements.
A full list of do’s and don’ts will be given to you by a member of our recruitment team if you are interested.
Clinical trial payment
In recognition of the time involved in taking part in the trial, you will receive £2,700 (£1,800 for completion and £900 for compliance) on completion of the clinical trial, provided you comply fully with all the clinical trial requirements. This amount is based on the anticipated clinical trial plan and will be adjusted pro-rata (i.e. same amount of money paid per unit of time), should we invite you to attend extra visits.
Dates
The trial will take place on the below time periods. You only need to attend one of the below periods for your in-house stay of 3 nights. You will then also be required to attend 11 follow-up sessions. Dates for follow up visits will be discussed with you by our team.
- 29th September – 2nd October 2025
- 1st – 4th October 2025
- 3rd – 6th November 2025
- 5th – 8th November 2025
- 7th – 10th December 2025
- 9th – 12th December 2025
- 26th – 29th January 2026
- 28th – 31st January 2026
Dates are subject to change. Please call a recruitment team member on 020 7042 5800 to discuss study dates, or register to receive a call back.
Approval
The contents of this page have been approved by an ethics committee. Any response to this advertisement will be recorded. Your response will not place you under any obligation to participate in this trial.
Ref: C25014_Jun-2025 (email_website_SMS_advert text)
